EMC aims to quintuple revenue in China
Company sees compound annual growth rate of 35 percent in the past five years
Fosun Pharma bidding $22.5 mln for U.S. Saladax
Fosun to hold majority of Saladax after the acquisition.
British Reckitt Benckiser buying into Chinese medicine firm
Foreign companies show increasing interest in traditional Chinese medicine.
Pfizer explore health products market in China
Foreign pharma firms look good in the new “blue ocean” of China
Chinese firm acquires Bayer U.S. research center
It’s the first time for a Chinese biotechnology company to acquire overseas research center of an international company.
American Stryker acquires Chinese Trauson for $764 mln
Stryker hopes to broaden presence in China
Fosun spends $468 mln starting reinsurance company
Company putting up 85 pct of venture investment
Medical and pharmaceutical industry to see M&A climax
Industry acquisitions valued over 10 billion yuan in 2012
China fosters bio-industry with special policies
China State Council planning to double bio-industry output value in 5 years
Fresh financing to help development of online Chinese healthcare
DXY completes B-round financing of about $100 million
Roche give first ever rights to a Chinese company
Chinese Techpool Bio-Pharma obtains franchise rights to Boniva
China supports local pediatric drug development
90 percent of local drugs do not have child-size dosage forms
China National Pharma seek overseas acquisitions
European tech companies the most sought-after targets.
Lundbeck to open its first Asian factory in Tianjin
Foreign neurologicalpharm giants fighting for promising Chinese market
Chinese medicine leads the growth in domestic pharmaceuticals
Chinese herbal pieces topped the growth rate at 27.8 percent to 9.7 billion yuan
Fosun Pharma officially lands on Hong Kong exchange
Stock code is 02196.HK